Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Endothelin-1 regulates cardiac sympathetic innervation in the rodent heart by controlling nerve growth factor expression
Masaki Ieda, … , Howard J. Federoff, Satoshi Ogawa
Masaki Ieda, … , Howard J. Federoff, Satoshi Ogawa
Published March 15, 2004
Citation Information: J Clin Invest. 2004;113(6):876-884. https://doi.org/10.1172/JCI19480.
View: Text | PDF
Article Cardiology

Endothelin-1 regulates cardiac sympathetic innervation in the rodent heart by controlling nerve growth factor expression

  • Text
  • PDF
Abstract

The cardiac sympathetic nerve plays an important role in regulating cardiac function, and nerve growth factor (NGF) contributes to its development and maintenance. However, little is known about the molecular mechanisms that regulate NGF expression and sympathetic innervation of the heart. In an effort to identify regulators of NGF in cardiomyocytes, we found that endothelin-1 specifically upregulated NGF expression in primary cultured cardiomyocytes. Endothelin-1–induced NGF augmentation was mediated by the endothelin-A receptor, Giβγ, PKC, the Src family, EGFR, extracellular signal–regulated kinase, p38MAPK, activator protein-1, and the CCAAT/enhancer-binding protein δ element. Either conditioned medium or coculture with endothelin-1–stimulated cardiomyocytes caused NGF-mediated PC12 cell differentiation. NGF expression, cardiac sympathetic innervation, and norepinephrine concentration were specifically reduced in endothelin-1–deficient mouse hearts, but not in angiotensinogen-deficient mice. In endothelin-1–deficient mice the sympathetic stellate ganglia exhibited excess apoptosis and displayed loss of neurons at the late embryonic stage. Furthermore, cardiac-specific overexpression of NGF in endothelin-1–deficient mice overcame the reduced sympathetic innervation and loss of stellate ganglia neurons. These findings indicate that endothelin-1 regulates NGF expression in cardiomyocytes and plays a critical role in sympathetic innervation of the heart.

Authors

Masaki Ieda, Keiichi Fukuda, Yasuyo Hisaka, Kensuke Kimura, Haruko Kawaguchi, Jun Fujita, Kouji Shimoda, Eiko Takeshita, Hideyuki Okano, Yukiko Kurihara, Hiroki Kurihara, Junji Ishida, Akiyoshi Fukamizu, Howard J. Federoff, Satoshi Ogawa

×

Figure 6

Options: View larger image (or click on image) Download as PowerPoint
Cardiac-specific overexpression of NGF overcomes the defects of the card...
Cardiac-specific overexpression of NGF overcomes the defects of the cardiac sympathetic nervous system in Edn1–/– mice. (A) NGF expression in Edn1+/+, Edn1–/–, and Edn1–/–/MHC-NGF hearts is shown (n = 6). The reduced NGF expression in the Edn1–/– heart was completely overcome by cardiac-specific overexpression of NGF. (B) Immunostaining for TH in the hearts of Edn1+/+, Edn1–/–, and Edn1–/–/MHC-NGF mice. Scale bar: 100 μm. (C) The immunopositive nerve areas for TH were quantitated (n = 6). (D) The cardiac norepinephrine (NE) concentration was increased in Edn1–/–/MHC-NGF mice compared with Edn1–/– mice (n = 6). (E) TH immunostaining, cresyl violet staining (CV), Ki-67 immunostaining, and TUNEL staining of Edn1+/+, Edn1–/–, and Edn1–/–/MHC-NGF SG at E18.5 at the same level of section. Note that the reduction of the size of SG and the increase in TUNEL+ cells in Edn1–/– mice were completely reversed in Edn1–/–/MHC-NGF mice. (F and G) The number of neurons and the number of TUNEL+ cells per 1,000 neurons in each SG are shown (n = 3–6). *P < 0.0001; **P < 0.01; #P < 0.05. TG, transgenic. Scale bar: 100 μm (TH), 50 μm (TUNEL), 10 μm (CV and Ki-67).

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts